Skip to main content

Market Overview

Meta Platforms, UnitedHealth Group And More: CNBC's 'Final Trades'

Share:
Meta Platforms, UnitedHealth Group And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Stephen L. Weiss of Short Hills Capital Partners said Meta Platforms, Inc. (NASDAQ:META) is selling at a discount to the market, which it should never do. So, the growth is still there, he added.

On Wednesday, Keybanc analyst Jason Celino maintained Meta with an Overweight rating and lowered the price target from $710 to $645, while B of A Securities analyst Justin Post maintained a Buy on the stock and cut the price target from $765 to $640.

Kari Firestone of Aureus Asset Management picked UnitedHealth Group Incorporated (NYSE:UNH), which has been in its own bear market. She noted that the stock is now starting to improve and is not affected by tariffs.

Supporting her view, Mizuho analyst Ann Hynes, on Wednesday, maintained UnitedHealth Group with an Outperform rating and raised the price target from $600 to $650.

Don't forget to check out our premarket coverage here

Bryn Talkington of Requisite Capital Management also picked Meta.

Joseph M. Terranova of Virtus Investment Partners suggested buying some calls in Invesco QQQ Trust (NASDAQ:QQQ) in case they bounce.

Price Action:

  • Meta shares gained 14.8% to close at $585.77 on Wednesday.
  • UnitedHealth shares rose 4.6% to close at $578.50 during Wednesday's session.
  • Invesco QQQ Trust jumped 12% during Wednesday's session.

Check This Out:

Photo: Shutterstock

 

Related Articles (QQQ + META)

View Comments and Join the Discussion!

Posted-In: Bryn Talkington Halftime Report Final Trades Joseph M. TerranovaLong Ideas News Markets Media Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com